Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Moderna Inc. (MRNA)

70.75   0.23 (0.33%) 10-01 09:13
Open: 72.51 Pre. Close: 70.52
High: 75.39 Low: 70.16
Volume: 15,540,331 Market Cap: 27,917M
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Cambridge, Massachusetts and currently employs 760 full-time employees. The company has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. The company is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. The company has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. The company has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 71.428 - 71.693 71.693 - 71.906
Low: 68.875 - 69.209 69.209 - 69.477
Close: 69.533 - 70.044 70.044 - 70.455

Technical analysis

as of: 2020-09-30 4:44:15 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 83.68     One year: 97.73
Support: Support1: 60.87    Support2: 54.21
Resistance: Resistance1: 71.64    Resistance2: 83.68
Pivot: 63.71
Moving Average: MA(5): 68.70     MA(20): 64.64
MA(100): 66.18     MA(250): 40.23
MACD: MACD(12,26): -0.32     Signal(9): -1.63
Stochastic oscillator: %K(14,3): 89.38     %D(3): 85.16
RSI: RSI(14): 56.62
52-week: High: 95.21  Low: 13.53  Change(%): 293.0
Average Vol(K): 3-Month: 2005736  10-Days: 997781

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MRNA has closed below upper band by 16.2%. Bollinger Bands are 6.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 30 Sep 2020
Moderna Inc. stock rises Wednesday, still underperforms market - MarketWatch

Wed, 30 Sep 2020
Does Moderna Inc (MRNA) Have What it Takes to be in Your Portfolio? - InvestorsObserver

Wed, 30 Sep 2020
How Many Moderna, Inc. (NASDAQ:MRNA) Shares Have Insiders Sold, In The Last Year? - Simply Wall St

Tue, 29 Sep 2020
Moderna Inc. stock outperforms market despite losses on the day - MarketWatch

Mon, 28 Sep 2020
Moderna Inc. stock rises Monday, still underperforms market - MarketWatch

Mon, 28 Sep 2020
Moderna (MRNA) Back In Rally Mode - Investopedia

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 395
Shares Float (M) 324
% Held by Insiders 23.94
% Held by Institutions 53.53
Shares Short (K) 28,020
Shares Short P. Month (K) 27,190

Stock Financials

EPS -1.390
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 7.490
Profit Margin
Operating Margin -485.03
Return on Assets (ttm) -12.4
Return on Equity (ttm) -22.8
Qtrly Rev. Growth 407.2
Gross Profit (p.s.) -1.105
Sales Per Share 0.268
EBITDA (p.s.) -1.222
Qtrly Earnings Growth
Operating Cash Flow (M) -336
Levered Free Cash Flow (M) -304

Stock Valuations

PE Ratio -50.38
PEG Ratio
Price to Book value 9.35
Price to Sales 261.08
Price to Cash Flow -82.20

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.